Skip to main content
OpenTrials

Clinical trial condition

Gastroesophageal Junction Adenocarcinoma

Explore clinical trials studying Gastroesophageal Junction Adenocarcinoma. Study availability and eligibility vary by location and protocol.

131 public trials 41 recruiting studies
Refine in advanced search Browse all conditions

Gastroesophageal Junction Adenocarcinoma trial results

Active, Not Recruiting

Durvalumab, an Anti-PDLI Antibody, and Tremelimumab, an Anti-CTLA4 Antibody, and Chemoradiation Before Surgery for Esophageal Cancer

NCT02962063

Conditions
Adenocarcinoma Of Esophagus, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
  • Memorial Sloan Kettering Westchester Harrison, New York, United States
View Trial Details
Active, Not Recruiting

Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

NCT03170960

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +68 more
Locations
  • Exelixis Clinical Site #53 Gilbert, Arizona, United States
  • Exelixis Clinical Site #18 Phoenix, Arizona, United States
  • Exelixis Clinical Site #1 Duarte, California, United States
  • Exelixis Clinical Site #20 La Jolla, California, United States
View all 124 locations
View Trial Details
Active, Not Recruiting

A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)

NCT05002127

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Adenocarcinoma, +8 more
Locations
  • The Oncology Institute of Hope & Innovation Anaheim, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Vanderbilt University Medical Center Nashville, Tennessee, United States
  • NEXT Virginia Fairfax, Virginia, United States
View all 83 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection

NCT04581473

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +12 more
Locations
  • Anhui Provincial Cancer Hospital Hefei, Anhui, China
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Peking University Shenzhen Hospital Shenzhen, Guangzhou, China
View all 24 locations
View Trial Details
Active, Not Recruiting

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC

NCT04140526

Conditions
Adenocarcinoma, Adenoid Cystic Carcinoma, Adnexal Diseases, +94 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • University of California at Davis Davis, California, United States
  • The Oncology Institute of Hope and Innovation Downey, California, United States
  • City of Hope Cancer Center Duarte, California, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

First in Human Study of TORL-2-307-MAB in Participants With Advanced Cancer

NCT05159440

Conditions
Advanced Solid Tumor, Digestive System Diseases, Digestive System Neoplasms, +13 more
Locations
  • Providence St. Jude Medical Center Fullerton, California, United States
  • UCLA - JCCC Clinical Research Unit Los Angeles, California, United States
  • Torrance Memorial Medical Torrance, California, United States
  • Fort Wayne Medical Oncology and Hematology Fort Wayne, Indiana, United States
View Trial Details

Related conditions